Skip to content
B
BiotechEdge
Start 14-Day Free Trial

Blueprint Medicines + Sanofi

closed

$BPMC acquired by Sanofi for $9.1B

Deal Summary

Deal Value
$9.1B
Price/Share
$129
Announced
Jun 2, 2025
Closed
Jul 18, 2025

Fund Positioning

6 of 20 tracked specialist biotech funds held $BPMC — based on SEC 13F filings.

FundSharesValueEntryAt Announcement
Eventide Asset Management729K$93.4MMar 2025Yes
Avoro Capital Advisors375K$48.1MMar 2025Yes
Casdin Capital326K$28.9MMar 2025Yes
Rock Springs Capital186K$23.8MMar 2025Yes
Driehaus Capital243K$21.5MMar 2025Yes
Baker Bros. Advisors126K$16.1MJun 2025No
← All biotech acquisitions